Clinical trial Recruiting at 1 site Interventional Ages 16 to 70

Epidural electrical stimulation to restore walking after spinal cord injury

Official title: Safety and Efficacy of Epidural Spinal Cord Stimulation for Restoring Walking in Spinal Cord Injury

Run by Second Affiliated Hospital, Zhejiang University, School of Medicine · NCT07306052 · Data updated 2026-11-12

This study will try epidural electrical stimulation combined with rehabilitation to help people with chronic AIS C–D spinal cord injuries improve their walking ability.

Quick facts

Study typeInterventional
Ages16 Years to 70 Years
SexAll
Enrollment12 (estimated)
SponsorSecond Affiliated Hospital, Zhejiang University, School of Medicine
Academic / other
Locations1 site (Hangzhou, Zhejiang)
StatusRecruiting
StartedDecember 12, 2025
Main results expectedJune 2027
Study endsJune 2027
Registry record updatedMay 29, 2026
Trial IDNCT07306052 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are people aged 16–65 with traumatic incomplete SCI (AIS C–D) 6–36 months after injury, injury level above T10, limited walking ability (WISCI II <13), preserved upper‑limb and sitting function, and measurable lower‑limb EMG responses to spinal stimulation.

Probably not a fit

People with complete injuries (AIS A–B), injuries below T10, inability to produce clear lower‑limb EMG responses, recent major cardiac or stroke events, or who cannot commit to intensive post‑operative rehabilitation are unlikely to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Participants will receive an implanted epidural electrical stimulation (EES) device followed by a structured, intensive rehabilitation program designed to promote stepping and overground walking. Functional assessments will be done before implantation and at 1, 3, 6, 9, and 12 months after implantation to track changes over time. Primary outcomes include the Walking Index for Spinal Cord Injury II (WISCI II), the 10‑Meter Walk Test, and the 6‑Minute Walk Test, with secondary measures such as ISNCSCI and SCIM III and electrophysiologic/imaging safety monitoring. The trial enrolls people with chronic incomplete traumatic SCI (AIS C–D) and is conducted at the Second Affiliated Hospital, School of Medicine, Zhejiang University in Hangzhou.

Why it matters

Potential benefit: If successful, this approach could improve walking speed, distance, and independence for some people with incomplete chronic spinal cord injury.

How similar studies have gone: Previous studies combining epidural stimulation with intensive rehabilitation have shown promising gains in voluntary movement and stepping for some individuals with incomplete SCI, but outcomes have varied and long‑term benefits remain under study.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age between 16 and 70 years.
* Diagnosed with traumatic spinal cord injury for ≥ 6 months and ≤ 60 months.
* American Spinal Injury Association Impairment Scale (AIS) grade B-D.
* Spinal cord injury level above T10;
* Walking Index for Spinal Cord Injury II (WISCI II) score ≤ 13.
* Completion of a standard conventional rehabilitation program prior to enrollment.
* Preserved upper limb function sufficient for self-propelling a manual wheelchair.
* Sitting balance grade ≥ 1.
* Ability to elicit clear electromyographic responses in lower limb muscles (e.g., rectus femoris, biceps femoris, gastrocnemius, tibialis anterior) upon transcutaneous electrical spinal cord stimulation at the T12-L1 vertebral levels.
* Willingness to voluntarily participate, and commitment to compliance with all necessary postoperative rehabilitation, assessments, and follow-up visits.

Exclusion Criteria:

* History of myocardial infarction or stroke within the past 6 months.
* Diagnosis of psychiatric disorders with active suicidal ideation or risk.
* Current pregnancy or planned pregnancy during the study period.
* Bleeding tendency or coagulopathy (prothrombin time ≥18 seconds).
* History of alcohol or substance abuse or dependence.
* Intellectual disability, cognitive impairment, or personality disorders.
* Other chronic medical conditions that may interfere with rehabilitation (e.g., unhealed severe fractures, hepatic or renal failure, severe anemia, etc.).
* Implantation of cardiac pacemakers, cardioverters, or defibrillators.
* Any other condition deemed inappropriate for participation by the investigators.

Where it's running

  • Second Affiliated Hospital, School of Medicine, Zhejiang University
    Hangzhou, Zhejiang, China
    Recruiting

Study contacts

  • Principal investigator: Junming Zhu — Second Affiliated Hospital, Zhejiang University, School of Medicine
  • Study coordinator: Junming Zhu, Chief Physician
  • Email: dr.zhujunming@zju.edu.cn
  • Phone: 0571-87784716

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.